AMETEK, Inc. recently released its 10-Q report. The company makes and sells electronic instruments and electromechanical devices in the U.S. and abroad, operating through two segments: Electronic Instruments Group and Electromechanical Group. Its products span process, aerospace, power, industrial, laboratory, medical, automation, and defense applications, and it is headquartered in Berwyn, Pennsylvania.
In Item 2, management said recent geopolitical developments, including the conflict involving Iran, have added uncertainty to global markets, though AMETEK said it has limited Middle East sales exposure and no material operations or assets in the region. The company also said tariff-related changes had no material impact on results for the six months ended June 30, 2026, but it continues to monitor pricing, supply chains, localization, and demand patterns as conditions evolve.
AMETEK disclosed that on May 5, 2026 it agreed to buy a portfolio of instrumentation businesses from Indicor, LLC in an all-cash deal valued at about $5.0 billion. Indicor Instrumentation has annual sales of about $1.1 billion, and the transaction is expected to close in the second half of 2026, subject to regulatory approvals and other closing conditions.
For the second quarter, AMETEK reported record net sales of $2.0444 billion, up 15.0% from $1.7781 billion a year earlier. Orders rose 28.2% to a record $2.2840 billion, and backlog reached a record $4.1102 billion at June 30, 2026, up from $3.5815 billion at year-end 2025.
International sales in the quarter were $963.7 million, or 47.1% of revenue, compared with $843.0 million, or 47.4%, in the prior-year quarter. Cost of sales increased to $1.3094 billion from $1.1422 billion, while consolidated operating income rose to $528.2 million from $461.6 million.
Quarterly net income climbed to a record $406.9 million from $358.4 million, and diluted earnings per share increased to a record $1.77 from $1.55. The effective tax rate fell to 17.4% from 19.0%.
Segment results showed EIG sales of $1.3212 billion, up 13.9%, with operating income of $369.7 million and margin of 28.0%, down from 29.7% a year earlier. EMG sales rose 16.9% to a record $723.2 million, with operating income of a record $189.3 million and margin of 26.2%, up from 23.3%.
For the first six months, AMETEK reported net sales of $3.9728 billion, up 13.2% from $3.5100 billion. Orders increased 25.7% to $4.5015 billion, and international sales rose to $1.8873 billion, or 47.5% of revenue, from $1.6475 billion, or 46.9%.
First-half operating income reached $1.0431 billion, up from $916.5 million, while net income increased to $806.3 million from $710.1 million. Diluted EPS rose to $3.51 from $3.07. AMETEK also recorded $16.2 million of pre-tax acquisition-related integration costs in the second quarter and $17.8 million for the first half tied to the FARO, LKC, and First Aviation deals. The market has reacted to these announcements by moving the company's shares 4.72% to a price of $255.275. Check out the company's full 10-Q submission here.
